secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2026-01-02T23:59:59+00:00
Accession:  0001104659-26-000243
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NWBO shareholders OK share increase to 2.6B, elect Pat Sarma
------------------------------------------------------------

- Authorized common shares increased from 1.7B to 2.6B; 89.65% of votes cast in favor.
- Over 77% of total voting power represented at annual meeting; quorum present.
- Pat Sarma elected as Class II director for three-year term with 81.1% of votes for.
- Ratified Cherry Bekaert LLP as independent auditor for FY2025 (93.76% for).
- Advisory vote on executive compensation approved with 77.23% of votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465926000243/0001104659-26-000243-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465926000243/tm261685d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-000243

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer